Prehabilitation & Rehabilitation in Oncogeriatrics: Adaptation to Deconditioning Risk and Accompaniment of Patients' With Cancer
NCT ID: NCT03659123
Last Updated: 2025-12-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
148 participants
INTERVENTIONAL
2018-07-03
2023-04-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Surgery or complex medico-surgical procedures - that associate chemotherapy and/or radiotherapy and surgery, can be considered as one proof-of principle of such risks, since major cancer surgery the older population is at higher risk of morbi-mortality and unplanned hospitalization for geriatric events In order to reduce complications after surgery, prehabilitation has often been considered, and 71% of the surgeons would accept a 4 weeks delay before surgery to improve patients' outcomes if shown to be beneficial. However, the actual level of evidence depends on the interventions: high for pre-operative nutrition, but low for physical exercise, due to heterogeneous programs with often bad adherence. In addition, geriatric validated interventions, in order to prevent iatrogenic event, may be added in a multi-interventional model of intervention.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Physical Activity Advices to Prevent Loss of Autonomy in Cancer Treated Elderly Patients. An Intervention Randomized Study
NCT01432067
Dynamics of Motivational Factors for Physical Activity and Nutrition in Oncogeriatrics
NCT06445140
Preparation for Medical and Surgical Procedures in Oncogeriatry.
NCT06443138
Optimization and Improvement of Care Course for 75 Years and Over Patient With Cancer and Living in Nursing Home on the Marseille Agglomeration
NCT03103659
PROADAPT-ovary/EWOC-2
NCT04284969
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This intervention was designed to be implemented pragmatically in the centers according local habits in several distinct hospital contexts in different tumor contexts.
It consists in:
1. before surgery: a prehabilitation of the patients including a nutritional, physical and educational preparation;
2. during the hospitalization for surgery: an optimisation of their treatments through a pharmaceutical conciliation, educational interventions, standardization of surgical procedures and enhanced rehabilitation after surgery;
3. bridging and post-discharge interventions for hospital-to-home transition.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
The intervention is designed to be implemented at different times of patients' care
During the prehabilitation time:
* Nutritional care
* Total-body rehabilitation
* Pharmaceutical conciliation During peri-operative time
* Management of enhances rehabilitation of the elderly. During rehabilitation time
* Nutritional, medication conciliation and functional follow-up During hospital-home transition time
* Nutritional and functional follow-up
* Optimisation of symptoms management: abdominal pain, nausea, vomiting…
standardized geriatric intervention
Nutritional care is based on:
* A personalized evaluation of nutritional balance and nutritional needs of the patient
* A weekly follow-up of weight and nutritional intake
Total-body rehabilitation is based on:
* 2 to 3 times a week: strength exercise
* 2 to 3 times a week: endurance exercise, 20 to 45 min each sequence
* 2 times a week: respiratory physiotherapy Pharmaceutical conciliation and optimization according STOPP/START criteria During peri-operative time, the nurse contacts the surgical team for transmission of patient's personal data, physical medication conciliation results During rehabilitation time and hospital-home transition time, the nurse contacts the rehabilitation team for transmission of patient's personal data and care course, physical (nutritional, functional and/or comorbidities), medication conciliation results.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
standardized geriatric intervention
Nutritional care is based on:
* A personalized evaluation of nutritional balance and nutritional needs of the patient
* A weekly follow-up of weight and nutritional intake
Total-body rehabilitation is based on:
* 2 to 3 times a week: strength exercise
* 2 to 3 times a week: endurance exercise, 20 to 45 min each sequence
* 2 times a week: respiratory physiotherapy Pharmaceutical conciliation and optimization according STOPP/START criteria During peri-operative time, the nurse contacts the surgical team for transmission of patient's personal data, physical medication conciliation results During rehabilitation time and hospital-home transition time, the nurse contacts the rehabilitation team for transmission of patient's personal data and care course, physical (nutritional, functional and/or comorbidities), medication conciliation results.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Histologically or cytologically proven cancer.
* Life expectancy \> 3 months.
* Written informed consent obtained
* Covered by a Health System where applicable.
Exclusion Criteria
* Patient unable to be regularly followed for any reason (geographic, familial, social, psychologic).
* Any mental or physical handicap at risk of interfering with the appropriate treatment.
* Any administrative or legal supervision where applicable
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Claire FALANDRY, MD
Role: PRINCIPAL_INVESTIGATOR
Hospices Civils de Lyon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier de Chambéry
Chambéry, , France
Centre hospitalier de Givors
Givors, , France
Centre Hospitalier Edouard Herriot
Lyon, , France
Hôpital Croix Rousse
Lyon, , France
Centre hospitalier d'Annecy Genevois
Metz-Tessy, , France
Centre Hospitalier Lyon Sud, Service d'Oncologie Médicale
Pierre-Bénite, , France
Centre Hospitalier Lyon Sud, Service de Gériatrie
Pierre-Bénite, , France
Centre hospitalier Universitaire de Saint Etienne
Saint-Etienne, , France
Hôpital Nord-Ouest
Villefranche-sur-Saône, , France
Clinique mutualiste Médipole
Villeurbanne, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Roche M, Ravot C, Malapert A, Paget-Bailly S, Garandeau C, Pitiot V, Tomatis M, Riche B, Galamand B, Granger M, Barbavara C, Bourgeois C, Genest E, Stefani L, Haine M, Castel-Kremer E, Morel-Soldner I, Collange V, Le Saux O, Dayde D, Falandry C; PROADAPT working group. Feasibility of a prehabilitation programme dedicated to older patients with cancer before complex medical-surgical procedures: the PROADAPT pilot study protocol. BMJ Open. 2021 Apr 2;11(4):e042960. doi: 10.1136/bmjopen-2020-042960.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69HCL16_0701
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.